“Patient- and Clinician-Reported Outcomes of Tirbanibulin 1% in the Treatment of Actinic Keratosis on the Face and Scalp (PROAK Study)”, J of Skin, vol. 7, no. 6, p. s262, Nov. 2023, doi: 10.25251/skin.7.supp.262.